Round Type
Seed
Ness Tsiona BiotechnologyHealth CareMedicalInvestors
Description
CardiaCare, a medical device company developing a breakthrough wearable technology for detecting, monitoring, and non-invasively treating cardiac arrhythmias using drug-free neuromodulation, recently closed an over-subscribed Seed Extension round. The financing was led by Solardis Health Ventures and supports efforts to expand the technology's clinical program for multiple indications related to treating Atrial Fibrillation (AFib). CardiaCare's platform can simultaneously help physicians remotely monitor their patients and create dynamic, personalized neuromodulation treatments based on the real-time patient's condition data. CardiaCare's mission is to become the new standard of care all-in-one therapeutic monitoring platform for cardiac arrhythmia patients across the continuum of care.
Quick answer
CardiaCare raised an undisclosed amount in a Seed round, dated September 18, 2023. Investors: Solardis Health Ventures. CardiaCare is based in Ness Tsiona , Israel.
- How much did CardiaCare raise?
- CardiaCare raised an undisclosed amount in a Seed round on September 18, 2023.
- Who invested in CardiaCare?
- Solardis Health Ventures is named as investors in this round.
- What does CardiaCare do?
- CardiaCare has developed the world's first wearable therapy for treating Atrial Fibrillation.
- Where is CardiaCare based and how big is it?
- CardiaCare is based in Ness Tsiona , Israel.
- Who are the decision-makers at CardiaCare?
- Fundz holds 1 contact at CardiaCare. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Biotechnology around the same time
Companies in the same sectors as CardiaCare that raised within 45 days of this round, from Fundz verified event records.
- Greenbrook TMS raised $2M (Seed) on November 2, 2023.
- HeartBeat.bio raised $4.8M (Seed) on November 2, 2023.
- Almouneer raised $3.6M (Seed) on October 31, 2023.
- Owl Peak Technologies raised an undisclosed amount (Funding Round) on October 27, 2023.
- Planatome raised $6M on October 25, 2023.
- Lipella Pharmaceuticals raised $3.1M (Seed) on October 23, 2023.
Who to call at CardiaCare, and when
A new round usually means CardiaCare is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day CardiaCare raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CardiaCare, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CardiaCare. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CardiaCare raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
CardiaCare raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.